Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Let’s dig into the relative performance of Corcept (NASDAQ:CORT) and its peers as we unravel the now-completed Q1 branded ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amphastar ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

The stock's fall snapped a four-day winning streak.

Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

With the stock currently trading at Rs 641.90, Syngene International showcases a moderate uptrend in today's session, amidst ...

analysis of the Phase 3... By Nate Raymond (NSE:RYMD) (Reuters) - Pfizer (NYSE:PFE) has resolved a lawsuit by a conservative group that alleged that a... Investing.com - Healthcare and vaccine ...

MphasiS's stock performance today reflects a positive shift, with a notable price increase. Investors and market participants ...

Online vehicle auction company Copart (NASDAQ:CPRT) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose ...

Real-time index price for S&P 500 Health Care [Sector] (SRHC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...